Hair Relaxer Lawsuit 2026: 11,000+ Cases and Growing

The hair relaxer cancer lawsuit — MDL 3060 — has grown into one of the largest mass tort litigations in the United States. As of early 2026, more than 11,000 women have filed claims against hair relaxer manufacturers including L'Oréal, Revlon, Namaste Laboratories, Strength of Nature, and others. The number grows every week.

Here is a comprehensive update on where things stand and what you need to know heading into 2026.

The Numbers

MDL 3060 Status — March 2026

Cases filed: 11,000+ (growing weekly)
Court: Northern District of Illinois, Judge Mary Rowland
Bellwether cases: 32 selected for early discovery and trial preparation
Punitive damages: Approved by court in September 2024
Daubert hearings: Scheduled mid-2026
First trial: Not expected before 2027
Settlement status: No global settlement reached

Why So Many Cases?

The rapid growth of the hair relaxer cancer MDL is driven by several factors:

The NIH Sister Study. The October 2022 study was a watershed moment. Before its publication, most women had no reason to connect their cancer diagnosis to hair relaxer use. After it was published, the connection became undeniable — and so did the legal accountability that followed.

Enormous affected population. Approximately 60% of Black women in the United States have used chemical hair relaxers. With 20+ million Black women as potential claimants — many of whom used these products for decades starting from childhood — the pool of potential plaintiffs is enormous.

Strong scientific evidence. The 2.55× uterine cancer risk finding from the NIH study is statistically robust and comes from one of the most prestigious research institutions in the world. This makes it very difficult for defendants to argue there is no scientific basis for the claims.

Punitive damages approval. Judge Rowland's September 2024 ruling approving punitive damages dramatically raised the stakes for the defendant manufacturers. Companies facing potential punitive damages have stronger financial incentives to settle cases.

The Bellwether Process in 2026

The 32 bellwether cases are currently in intensive discovery. Both sides are exchanging documents, taking depositions of company executives and scientists, and developing expert witnesses. These cases will eventually go to trial — and the outcomes will heavily influence settlement negotiations for the entire MDL.

The most critical upcoming milestone is the Daubert hearing in mid-2026. At these hearings, Judge Rowland will rule on whether plaintiffs' scientific experts can testify that hair relaxers cause the cancers alleged. If the court allows this expert testimony, it significantly strengthens plaintiffs' position for trials and settlement.

What This Means for New Claimants

If you used chemical hair relaxers and have been diagnosed with uterine cancer, ovarian cancer, endometriosis, or uterine fibroids, you can still file a claim. The MDL is actively accepting new cases.

Filing sooner is generally better than filing later for several reasons:

Statutes of limitations are running — some states have 2-year or even 1-year filing windows
Evidence (medical records, witness memories, product records) is easier to gather now than years from now
In many mass tort settlements, earlier-filed cases are treated more favorably in compensation structures
Once a settlement is announced, filing windows for new claims often close rapidly

Claims Are Still Open — Don't Wait

Over 11,000 women have already filed. The litigation is active and growing. A free case evaluation takes 2 minutes.

Check My Eligibility →

Disclaimer: This article is for educational purposes only and is not legal advice. Litigation status changes frequently. Consult a licensed attorney for current guidance specific to your situation.